Treatment with rosmarinic acid dramatically reduced melanoma cell viability, proliferation, migratory, invasive, and chemotherapy sensitivity by inhibiting ADAM17/EGFR/AKT/GSK3β [84]. Here, EGFR is linked to melanoma.